Skip to main content
Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
13.29
+0.17 (1.30%)
At close: Mar 9, 2026, 4:00 PM EDT
12.90
-0.39 (-2.93%)
After-hours: Mar 9, 2026, 7:32 PM EDT

Wave Life Sciences Revenue

In the year 2025, Wave Life Sciences had annual revenue of $42.73M, down -60.55%. Wave Life Sciences had revenue of $17.25M in the quarter ending December 31, 2025, a decrease of -79.41%.

Revenue (ttm)
$42.73M
Revenue Growth
-60.55%
P/S Ratio
58.56
Revenue / Employee
$134,785
Employees
317
Market Cap
2.50B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202542.73M-65.58M-60.55%
Dec 31, 2024108.30M-5.00M-4.42%
Dec 31, 2023113.31M109.66M3,005.10%
Dec 31, 20223.65M-37.32M-91.09%
Dec 31, 202140.96M20.89M104.03%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Apellis Pharmaceuticals 1.00B
Telix Pharmaceuticals 803.79M
Travere Therapeutics 490.73M
Adaptive Biotechnologies 276.98M
Day One Biopharmaceuticals 158.18M
Beam Therapeutics 139.74M
Tango Therapeutics 62.38M
Ocular Therapeutix 51.95M
Revenue Rankings

WVE News

More News